Chemed (CHE) PT Raised to $275 at Oppenheimer Following 4Q Beat

February 15, 2018 10:17 AM

Oppenheimer raised its price target on Chemed (NYSE: CHE) to $275.00 (from $270.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found